Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Form 8 (OPD) - Gresham Technologies Plc

15 Apr 2024 17:32

RNS Number : 6969K
Gresham Technologies PLC
15 April 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

GRESHAM TECHNOLOGIES PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GRESHAM TECHNOLOGIES PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

15/4/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(a) Ordinary shares of £0.05 each in the capital of Gresham Technologies plc ("Ordinary Shares") held by the directors of Gresham Technologies plc, their close relatives and related trusts (excluding options which are set out in (b) below:

Director

Number of Ordinary Shares

Percentage of issued share capital

Ian Manocha

166,640

0.20

Thomas Mullan

76,054

0.09

Andrew Balchin

17,608

0.02

Jennifer Knott

31,250

0.04

Oliver Scott

155,434

0.19

 

(b) Options and awards held by the directors of Gresham Technologies plc, their close relatives and related trusts:

Director

Number of Ordinary Shares under option

Vesting details

Exercise Price

Ian Manocha

1,500,000

Granted on 1 June 2015

Vested on 31 May 2018

Expires on 29 May 2025

£1.11

104,008

Granted on 18 March 2020

Vested on 18 March 2023

Expires on 18 March 2030

Nil

Up to 174,944

Granted on 31 March 2022

Vesting on 31 March 2025

Expires on 31 March 2032

Nil

Up to 135,000

Granted on 21 October 2021

Vesting on 20 October 2024

Expires on 19 October 2031

Nil

Up to 68,000

Granted on 21 October 2021

Vesting on 20 October 2024

Expires on 19 October 2031

Nil

Up to 197,185

Granted on 31 March 2023

Vesting on 31 March 2026

Expires on 31 March 2033

Nil

Thomas Mullan

200,000

Granted on 14 March 2018

Vested on 13 March 2021

Expires on 11 March 2028

£2.27

100,000

Granted on 28 March 2019

Vested on 27 March 2022

Expires on 25 March 2029

£0.97

67,532

Granted on 18 March 2020

Vested on 18 March 2023

Expires on 18 March 2030

Nil

Up to 107,736

Granted on 31 March 2022

Vesting on 31 March 2025

Expires on 31 March 2032

Nil

Up to 75,000

Granted on 21 October 2021

Vesting on 20 October 2024

Expires on 19 October 2031

Nil

Up to 118,919

Granted on 31 March 2023

Vesting on 31 March 2026

Expires on 31 March 2033

Nil

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

15/4/2024

Contact name:

Jonathan Cathie

Telephone number:

+44 (0) 207 653 0290

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAKLSFDFLEFA
Date   Source Headline
23rd Dec 20202:00 pmRNSSignificant Clareti Contract Win with Global Bank
11th Dec 20207:00 amRNSNotice of General Meeting and Circular
3rd Dec 202012:37 pmRNSExercise of Options
23rd Nov 20207:00 amRNSSignificant Clareti Contract with Global Bank
2nd Nov 20202:17 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSTrading Update
15th Oct 20207:00 amRNSExercise of Options
12th Oct 20207:00 amRNSBoard Changes
5th Oct 20207:00 amRNSExercise of Options
23rd Sep 202012:24 pmRNSExercise of Options
15th Sep 20205:04 pmRNSHolding(s) in Company
30th Jul 202012:28 pmRNSChairman designate dealing
29th Jul 20207:00 amRNSAcquisition of Inforalgo Information Technology
28th Jul 20204:35 pmRNSHolding(s) in Company
28th Jul 20201:34 pmRNSHolding(s) in Company
21st Jul 20207:01 amRNSBoard Changes
21st Jul 20207:00 amRNSHalf-year Report
16th Jul 20207:00 amRNSNotice of Interim Results and Presentations
6th Jul 20201:42 pmRNSHolding(s) in Company
6th Jul 20201:40 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSTrading Update
11th Jun 20203:21 pmRNSHolding(s) in Company
10th Jun 202012:00 pmRNSSignificant Clareti Contract Win with Global Bank
4th Jun 202010:28 amRNSPDMR Dealing
19th May 20201:03 pmRNSHolding(s) in Company
14th May 202012:23 pmRNSResult of AGM
14th May 20207:00 amRNSAGM Statement
6th May 20207:00 amRNSAGM Change of Location
20th Apr 20207:00 amRNSTrading Update – COVID-19 Impact
2nd Apr 20207:00 amRNSNotice of AGM and Dividend Timetable
31st Mar 20207:00 amRNSDirectors Share Awards
27th Mar 20201:33 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20201:58 pmRNSUpdate on Private Investor Presentation
4th Mar 20207:00 amRNSNotice of Results & Analyst Presentation
3rd Feb 20207:00 amRNSElectronic Communications
28th Jan 20203:13 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSTrading Update
3rd Jan 20201:27 pmRNSHolding(s) in Company
27th Dec 20192:55 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSClareti Contract Win and Trading Update
25th Sep 20197:00 amRNSExercise of Options
20th Sep 20197:00 amRNSGresham and ANZ partnership
2nd Sep 201911:11 amRNSHolding(s) in Company
2nd Aug 20195:46 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNotice of Results & Analyst Presentation
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSStrategic fintech partner signs Clareti agreement
5th Jun 20199:56 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.